Drug intelligence / Profile preview

Alodase

Development stage
Unknown
Lead developer
Wellmed Pharma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

**Alodase** is a Wellmed Pharma branded fixed-dose oral tablet containing aceclofenac 100 mg, paracetamol 325 mg, and serratiopeptidase 15 mg. Aceclofenac is a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase-mediated prostaglandin synthesis; paracetamol provides analgesic and antipyretic activity through incompletely resolved, predominantly central mechanisms that include cyclooxygenase-pathway modulation; and serratiopeptidase is a proteolytic enzyme used for anti-inflammatory and anti-edema effects. The product is marketed for pain and inflammation, including musculoskeletal pain and postoperative inflammatory swelling. ([wellmedpharma.com](https://www.wellmedpharma.com/product/alodase/))

Brand names
Alodase
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Alodase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alodase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call